Receive conference highlights, journal articles, and online medical education activities straight to your inbox.
Trending Topic
Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane)Â and selective oestrogen receptor degraders (SERDs; fulvestrant […]
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.